Medical Care
Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Research Report 2025
- May 12, 25
- ID: 235918
- Pages: 100
- Figures: 100
- Views: 28
The global market for Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The latex particle-enhanced immunoturbidimetric immunoassay (PETIA) is a particle-enhanced turbidimetric immunoassay technology that utilizes the particle enhancement effect and combines immunological principles to quantitatively determine the concentration of specific proteins in body fluids. In PETIA, the substance to be detected binds to a specific antibody to form an immune complex, and then latex particles (usually polystyrene particles) with affinity are added, which bind to the immune complex and form clumps. When immune complexes bind to latex particles, a turbid solution results. Next, an optical instrument is used to measure the turbidity of the solution, which is proportional to the concentration of the substance to be measured.
The PETIA technology has the advantages of high sensitivity, easy operation, and high degree of automation. It can be used to measure proteins, hormones, tumor markers in serum, which is of great significance.
This report aims to provide a comprehensive presentation of the global market for Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA).
The Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gentian Diagnostics
Thermo Fisher Scientific
Buehlmann
Biotec
Abbott Laboratories
Roche
Siemens
Danaher Corporation
Diasorin SPA
Sysmex Corporation
Biomerieux
QIAGEN
Agilent Technologies
Cnpair Biotech
Diagvita
Enriching Biotechnology
Segment by Type
Scattering Nephelometric Detection Method
Transmittance Nephelometric Detection Method
Segment by Application
Reagent
Instrument
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The latex particle-enhanced immunoturbidimetric immunoassay (PETIA) is a particle-enhanced turbidimetric immunoassay technology that utilizes the particle enhancement effect and combines immunological principles to quantitatively determine the concentration of specific proteins in body fluids. In PETIA, the substance to be detected binds to a specific antibody to form an immune complex, and then latex particles (usually polystyrene particles) with affinity are added, which bind to the immune complex and form clumps. When immune complexes bind to latex particles, a turbid solution results. Next, an optical instrument is used to measure the turbidity of the solution, which is proportional to the concentration of the substance to be measured.
The PETIA technology has the advantages of high sensitivity, easy operation, and high degree of automation. It can be used to measure proteins, hormones, tumor markers in serum, which is of great significance.
This report aims to provide a comprehensive presentation of the global market for Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA).
The Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Gentian Diagnostics
Thermo Fisher Scientific
Buehlmann
Biotec
Abbott Laboratories
Roche
Siemens
Danaher Corporation
Diasorin SPA
Sysmex Corporation
Biomerieux
QIAGEN
Agilent Technologies
Cnpair Biotech
Diagvita
Enriching Biotechnology
Segment by Type
Scattering Nephelometric Detection Method
Transmittance Nephelometric Detection Method
Segment by Application
Reagent
Instrument
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Scattering Nephelometric Detection Method
1.2.3 Transmittance Nephelometric Detection Method
1.3 Market by Application
1.3.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Reagent
1.3.3 Instrument
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Perspective (2020-2031)
2.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Growth Trends by Region
2.2.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Historic Market Size by Region (2020-2025)
2.2.3 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Region (2026-2031)
2.3 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Dynamics
2.3.1 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Industry Trends
2.3.2 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Drivers
2.3.3 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Challenges
2.3.4 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Players by Revenue
3.1.1 Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Players by Revenue (2020-2025)
3.1.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Players (2020-2025)
3.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue
3.4 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Concentration Ratio
3.4.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue in 2024
3.5 Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Head office and Area Served
3.6 Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Product and Application
3.7 Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Breakdown Data by Type
4.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Historic Market Size by Type (2020-2025)
4.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Type (2026-2031)
5 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Breakdown Data by Application
5.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Historic Market Size by Application (2020-2025)
5.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)
6.2 North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025)
6.4 North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)
7.2 Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025)
7.4 Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)
8.2 Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2020-2025)
8.4 Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)
9.2 Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025)
9.4 Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)
10.2 Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025)
10.4 Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gentian Diagnostics
11.1.1 Gentian Diagnostics Company Details
11.1.2 Gentian Diagnostics Business Overview
11.1.3 Gentian Diagnostics Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.1.4 Gentian Diagnostics Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.1.5 Gentian Diagnostics Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.2.4 Thermo Fisher Scientific Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Buehlmann
11.3.1 Buehlmann Company Details
11.3.2 Buehlmann Business Overview
11.3.3 Buehlmann Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.3.4 Buehlmann Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.3.5 Buehlmann Recent Development
11.4 Biotec
11.4.1 Biotec Company Details
11.4.2 Biotec Business Overview
11.4.3 Biotec Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.4.4 Biotec Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.4.5 Biotec Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.5.4 Abbott Laboratories Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.5.5 Abbott Laboratories Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.6.4 Roche Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.6.5 Roche Recent Development
11.7 Siemens
11.7.1 Siemens Company Details
11.7.2 Siemens Business Overview
11.7.3 Siemens Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.7.4 Siemens Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.7.5 Siemens Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.8.4 Danaher Corporation Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.8.5 Danaher Corporation Recent Development
11.9 Diasorin SPA
11.9.1 Diasorin SPA Company Details
11.9.2 Diasorin SPA Business Overview
11.9.3 Diasorin SPA Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.9.4 Diasorin SPA Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.9.5 Diasorin SPA Recent Development
11.10 Sysmex Corporation
11.10.1 Sysmex Corporation Company Details
11.10.2 Sysmex Corporation Business Overview
11.10.3 Sysmex Corporation Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.10.4 Sysmex Corporation Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.10.5 Sysmex Corporation Recent Development
11.11 Biomerieux
11.11.1 Biomerieux Company Details
11.11.2 Biomerieux Business Overview
11.11.3 Biomerieux Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.11.4 Biomerieux Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.11.5 Biomerieux Recent Development
11.12 QIAGEN
11.12.1 QIAGEN Company Details
11.12.2 QIAGEN Business Overview
11.12.3 QIAGEN Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.12.4 QIAGEN Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.12.5 QIAGEN Recent Development
11.13 Agilent Technologies
11.13.1 Agilent Technologies Company Details
11.13.2 Agilent Technologies Business Overview
11.13.3 Agilent Technologies Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.13.4 Agilent Technologies Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.13.5 Agilent Technologies Recent Development
11.14 Cnpair Biotech
11.14.1 Cnpair Biotech Company Details
11.14.2 Cnpair Biotech Business Overview
11.14.3 Cnpair Biotech Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.14.4 Cnpair Biotech Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.14.5 Cnpair Biotech Recent Development
11.15 Diagvita
11.15.1 Diagvita Company Details
11.15.2 Diagvita Business Overview
11.15.3 Diagvita Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.15.4 Diagvita Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.15.5 Diagvita Recent Development
11.16 Enriching Biotechnology
11.16.1 Enriching Biotechnology Company Details
11.16.2 Enriching Biotechnology Business Overview
11.16.3 Enriching Biotechnology Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.16.4 Enriching Biotechnology Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.16.5 Enriching Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Scattering Nephelometric Detection Method
1.2.3 Transmittance Nephelometric Detection Method
1.3 Market by Application
1.3.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Reagent
1.3.3 Instrument
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Perspective (2020-2031)
2.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Growth Trends by Region
2.2.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Historic Market Size by Region (2020-2025)
2.2.3 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Region (2026-2031)
2.3 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Dynamics
2.3.1 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Industry Trends
2.3.2 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Drivers
2.3.3 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Challenges
2.3.4 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Players by Revenue
3.1.1 Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Players by Revenue (2020-2025)
3.1.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Players (2020-2025)
3.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue
3.4 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Concentration Ratio
3.4.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue in 2024
3.5 Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Head office and Area Served
3.6 Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Product and Application
3.7 Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Breakdown Data by Type
4.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Historic Market Size by Type (2020-2025)
4.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Type (2026-2031)
5 Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Breakdown Data by Application
5.1 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Historic Market Size by Application (2020-2025)
5.2 Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)
6.2 North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025)
6.4 North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)
7.2 Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025)
7.4 Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)
8.2 Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2020-2025)
8.4 Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)
9.2 Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025)
9.4 Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (2020-2031)
10.2 Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025)
10.4 Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gentian Diagnostics
11.1.1 Gentian Diagnostics Company Details
11.1.2 Gentian Diagnostics Business Overview
11.1.3 Gentian Diagnostics Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.1.4 Gentian Diagnostics Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.1.5 Gentian Diagnostics Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.2.4 Thermo Fisher Scientific Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Buehlmann
11.3.1 Buehlmann Company Details
11.3.2 Buehlmann Business Overview
11.3.3 Buehlmann Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.3.4 Buehlmann Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.3.5 Buehlmann Recent Development
11.4 Biotec
11.4.1 Biotec Company Details
11.4.2 Biotec Business Overview
11.4.3 Biotec Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.4.4 Biotec Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.4.5 Biotec Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.5.4 Abbott Laboratories Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.5.5 Abbott Laboratories Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.6.4 Roche Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.6.5 Roche Recent Development
11.7 Siemens
11.7.1 Siemens Company Details
11.7.2 Siemens Business Overview
11.7.3 Siemens Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.7.4 Siemens Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.7.5 Siemens Recent Development
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Details
11.8.2 Danaher Corporation Business Overview
11.8.3 Danaher Corporation Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.8.4 Danaher Corporation Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.8.5 Danaher Corporation Recent Development
11.9 Diasorin SPA
11.9.1 Diasorin SPA Company Details
11.9.2 Diasorin SPA Business Overview
11.9.3 Diasorin SPA Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.9.4 Diasorin SPA Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.9.5 Diasorin SPA Recent Development
11.10 Sysmex Corporation
11.10.1 Sysmex Corporation Company Details
11.10.2 Sysmex Corporation Business Overview
11.10.3 Sysmex Corporation Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.10.4 Sysmex Corporation Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.10.5 Sysmex Corporation Recent Development
11.11 Biomerieux
11.11.1 Biomerieux Company Details
11.11.2 Biomerieux Business Overview
11.11.3 Biomerieux Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.11.4 Biomerieux Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.11.5 Biomerieux Recent Development
11.12 QIAGEN
11.12.1 QIAGEN Company Details
11.12.2 QIAGEN Business Overview
11.12.3 QIAGEN Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.12.4 QIAGEN Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.12.5 QIAGEN Recent Development
11.13 Agilent Technologies
11.13.1 Agilent Technologies Company Details
11.13.2 Agilent Technologies Business Overview
11.13.3 Agilent Technologies Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.13.4 Agilent Technologies Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.13.5 Agilent Technologies Recent Development
11.14 Cnpair Biotech
11.14.1 Cnpair Biotech Company Details
11.14.2 Cnpair Biotech Business Overview
11.14.3 Cnpair Biotech Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.14.4 Cnpair Biotech Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.14.5 Cnpair Biotech Recent Development
11.15 Diagvita
11.15.1 Diagvita Company Details
11.15.2 Diagvita Business Overview
11.15.3 Diagvita Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.15.4 Diagvita Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.15.5 Diagvita Recent Development
11.16 Enriching Biotechnology
11.16.1 Enriching Biotechnology Company Details
11.16.2 Enriching Biotechnology Business Overview
11.16.3 Enriching Biotechnology Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Introduction
11.16.4 Enriching Biotechnology Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
11.16.5 Enriching Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Scattering Nephelometric Detection Method
Table 3. Key Players of Transmittance Nephelometric Detection Method
Table 4. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Region (2020-2025)
Table 8. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Region (2026-2031)
Table 10. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Trends
Table 11. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Drivers
Table 12. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Challenges
Table 13. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Restraints
Table 14. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Players (2020-2025)
Table 16. Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) as of 2024)
Table 17. Ranking of Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Headquarters and Area Served
Table 20. Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Product and Application
Table 21. Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Type (2020-2025)
Table 25. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Type (2026-2031)
Table 27. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Application (2020-2025)
Table 29. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Application (2026-2031)
Table 31. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Gentian Diagnostics Company Details
Table 47. Gentian Diagnostics Business Overview
Table 48. Gentian Diagnostics Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 49. Gentian Diagnostics Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 50. Gentian Diagnostics Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 54. Thermo Fisher Scientific Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Buehlmann Company Details
Table 57. Buehlmann Business Overview
Table 58. Buehlmann Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 59. Buehlmann Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 60. Buehlmann Recent Development
Table 61. Biotec Company Details
Table 62. Biotec Business Overview
Table 63. Biotec Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 64. Biotec Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 65. Biotec Recent Development
Table 66. Abbott Laboratories Company Details
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 69. Abbott Laboratories Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 70. Abbott Laboratories Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 74. Roche Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Siemens Company Details
Table 77. Siemens Business Overview
Table 78. Siemens Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 79. Siemens Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 80. Siemens Recent Development
Table 81. Danaher Corporation Company Details
Table 82. Danaher Corporation Business Overview
Table 83. Danaher Corporation Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 84. Danaher Corporation Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 85. Danaher Corporation Recent Development
Table 86. Diasorin SPA Company Details
Table 87. Diasorin SPA Business Overview
Table 88. Diasorin SPA Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 89. Diasorin SPA Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 90. Diasorin SPA Recent Development
Table 91. Sysmex Corporation Company Details
Table 92. Sysmex Corporation Business Overview
Table 93. Sysmex Corporation Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 94. Sysmex Corporation Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 95. Sysmex Corporation Recent Development
Table 96. Biomerieux Company Details
Table 97. Biomerieux Business Overview
Table 98. Biomerieux Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 99. Biomerieux Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 100. Biomerieux Recent Development
Table 101. QIAGEN Company Details
Table 102. QIAGEN Business Overview
Table 103. QIAGEN Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 104. QIAGEN Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 105. QIAGEN Recent Development
Table 106. Agilent Technologies Company Details
Table 107. Agilent Technologies Business Overview
Table 108. Agilent Technologies Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 109. Agilent Technologies Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 110. Agilent Technologies Recent Development
Table 111. Cnpair Biotech Company Details
Table 112. Cnpair Biotech Business Overview
Table 113. Cnpair Biotech Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 114. Cnpair Biotech Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 115. Cnpair Biotech Recent Development
Table 116. Diagvita Company Details
Table 117. Diagvita Business Overview
Table 118. Diagvita Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 119. Diagvita Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 120. Diagvita Recent Development
Table 121. Enriching Biotechnology Company Details
Table 122. Enriching Biotechnology Business Overview
Table 123. Enriching Biotechnology Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 124. Enriching Biotechnology Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 125. Enriching Biotechnology Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Picture
Figure 2. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Type: 2024 VS 2031
Figure 4. Scattering Nephelometric Detection Method Features
Figure 5. Transmittance Nephelometric Detection Method Features
Figure 6. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Application: 2024 VS 2031
Figure 8. Reagent Case Studies
Figure 9. Instrument Case Studies
Figure 10. Others Case Studies
Figure 11. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Report Years Considered
Figure 12. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Region: 2024 VS 2031
Figure 15. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Players in 2024
Figure 16. Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue in 2024
Figure 18. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Country (2020-2031)
Figure 20. United States Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Country (2020-2031)
Figure 24. Germany Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Region (2020-2031)
Figure 32. China Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Country (2020-2031)
Figure 40. Mexico Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Country (2020-2031)
Figure 44. Turkey Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Gentian Diagnostics Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 49. Buehlmann Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 50. Biotec Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 51. Abbott Laboratories Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 53. Siemens Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 54. Danaher Corporation Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 55. Diasorin SPA Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 56. Sysmex Corporation Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 57. Biomerieux Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 58. QIAGEN Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 59. Agilent Technologies Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 60. Cnpair Biotech Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 61. Diagvita Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 62. Enriching Biotechnology Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Scattering Nephelometric Detection Method
Table 3. Key Players of Transmittance Nephelometric Detection Method
Table 4. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Region (2020-2025)
Table 8. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Region (2026-2031)
Table 10. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Trends
Table 11. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Drivers
Table 12. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Challenges
Table 13. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Restraints
Table 14. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Players (2020-2025)
Table 16. Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) as of 2024)
Table 17. Ranking of Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Headquarters and Area Served
Table 20. Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Product and Application
Table 21. Global Key Players of Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Type (2020-2025)
Table 25. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Type (2026-2031)
Table 27. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Application (2020-2025)
Table 29. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue Market Share by Application (2026-2031)
Table 31. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Gentian Diagnostics Company Details
Table 47. Gentian Diagnostics Business Overview
Table 48. Gentian Diagnostics Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 49. Gentian Diagnostics Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 50. Gentian Diagnostics Recent Development
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 54. Thermo Fisher Scientific Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Buehlmann Company Details
Table 57. Buehlmann Business Overview
Table 58. Buehlmann Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 59. Buehlmann Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 60. Buehlmann Recent Development
Table 61. Biotec Company Details
Table 62. Biotec Business Overview
Table 63. Biotec Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 64. Biotec Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 65. Biotec Recent Development
Table 66. Abbott Laboratories Company Details
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 69. Abbott Laboratories Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 70. Abbott Laboratories Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 74. Roche Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Siemens Company Details
Table 77. Siemens Business Overview
Table 78. Siemens Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 79. Siemens Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 80. Siemens Recent Development
Table 81. Danaher Corporation Company Details
Table 82. Danaher Corporation Business Overview
Table 83. Danaher Corporation Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 84. Danaher Corporation Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 85. Danaher Corporation Recent Development
Table 86. Diasorin SPA Company Details
Table 87. Diasorin SPA Business Overview
Table 88. Diasorin SPA Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 89. Diasorin SPA Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 90. Diasorin SPA Recent Development
Table 91. Sysmex Corporation Company Details
Table 92. Sysmex Corporation Business Overview
Table 93. Sysmex Corporation Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 94. Sysmex Corporation Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 95. Sysmex Corporation Recent Development
Table 96. Biomerieux Company Details
Table 97. Biomerieux Business Overview
Table 98. Biomerieux Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 99. Biomerieux Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 100. Biomerieux Recent Development
Table 101. QIAGEN Company Details
Table 102. QIAGEN Business Overview
Table 103. QIAGEN Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 104. QIAGEN Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 105. QIAGEN Recent Development
Table 106. Agilent Technologies Company Details
Table 107. Agilent Technologies Business Overview
Table 108. Agilent Technologies Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 109. Agilent Technologies Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 110. Agilent Technologies Recent Development
Table 111. Cnpair Biotech Company Details
Table 112. Cnpair Biotech Business Overview
Table 113. Cnpair Biotech Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 114. Cnpair Biotech Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 115. Cnpair Biotech Recent Development
Table 116. Diagvita Company Details
Table 117. Diagvita Business Overview
Table 118. Diagvita Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 119. Diagvita Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 120. Diagvita Recent Development
Table 121. Enriching Biotechnology Company Details
Table 122. Enriching Biotechnology Business Overview
Table 123. Enriching Biotechnology Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Product
Table 124. Enriching Biotechnology Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025) & (US$ Million)
Table 125. Enriching Biotechnology Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Picture
Figure 2. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Type: 2024 VS 2031
Figure 4. Scattering Nephelometric Detection Method Features
Figure 5. Transmittance Nephelometric Detection Method Features
Figure 6. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Application: 2024 VS 2031
Figure 8. Reagent Case Studies
Figure 9. Instrument Case Studies
Figure 10. Others Case Studies
Figure 11. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Report Years Considered
Figure 12. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Region: 2024 VS 2031
Figure 15. Global Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Players in 2024
Figure 16. Global Top Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Revenue in 2024
Figure 18. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Country (2020-2031)
Figure 20. United States Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Country (2020-2031)
Figure 24. Germany Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Region (2020-2031)
Figure 32. China Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Country (2020-2031)
Figure 40. Mexico Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Share by Country (2020-2031)
Figure 44. Turkey Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Gentian Diagnostics Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 49. Buehlmann Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 50. Biotec Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 51. Abbott Laboratories Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 53. Siemens Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 54. Danaher Corporation Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 55. Diasorin SPA Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 56. Sysmex Corporation Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 57. Biomerieux Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 58. QIAGEN Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 59. Agilent Technologies Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 60. Cnpair Biotech Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 61. Diagvita Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 62. Enriching Biotechnology Revenue Growth Rate in Latex Particle-Enhanced Turbidimetric Immunoassay (PETIA) Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232